← All diseases Cancer

Chronic lymphocytic leukemia

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (63)Meta-analysis (7)Treatment guideline (3)Phase 3 study (32)Systematic review (13)Randomized trial (8)Clinical trial (588)Review article (208)Early study (phase 1 or 2) (38)Case report (197)Laboratory or animal study (14)Commentary or editorial (62)Retracted publication (2) Studies currently seeking participants only (43)

Filter

Publications and studies (1769)

• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma. (2023/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia. (2023/03/01) ♡
• Oral azole antifungal prophylaxis in Japanese patients with chronic lymphocytic leukemia receiving ibrutinib: a nationwide cohort study. (2023/03/01) ♡
• In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities. (2023/03/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Biology and treatment of high-risk CLL. (2023/02/20) ♡
• Direct Cell Death Induced by CD20 Monoclonal Antibodies on B Cell Lymphoma Cells Revealed by New Protocols of Analysis. (2023/02/09) ♡
• Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism. (2023/02/07) ♡
• Rohitukine content across the geographical distribution of Dysoxylum binectariferum Hook F. and its natural derivatives as potential sources of CDK inhibitors. (2023/02/03) ♡
• Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selection. (2023/02/01) ♡
• Risk of primary haematologic cancers following incident non-metastatic breast cancer: A Danish population-based cohort study. (2023/02/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Quality of the control arms in randomized trials of chronic lymphocytic leukemia enrolling in the USA: A systematic review. (2023/02/01) ♡
• Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. (2023/02/01) ♡
• Mass balance, metabolic disposition, and pharmacokinetics of a novel selective inhibitor of PI3Kδ [(14)C] SHC014748M in healthy Chinese subjects following oral administration. (2023/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. 68Ga-DOTATATE PET/CT Incidentally Detects Relapsed Chronic Lymphocytic Leukemia in Patient With Metastatic Neuroendocrine Tumor. (2023/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Epidermotropic B-Cell Lymphoma: A Case of Secondary Cutaneous Splenic Marginal Zone B-Cell Lymphoma With Autoinvolutive and Recurrent Cutaneous Lesions. (2023/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The molecular and clinical significance of the Tie/angiopoietin system in leukemia. (2023/02/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. (2023/01/26) ♡
• Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis. (2023/01/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: A review. (2023/01/18) ♡
• Stromal cells support the survival of human primary chronic lymphocytic leukemia (CLL) cells through Lyn-driven extracellular vesicles. (2023/01/13) ♡
• Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia. (2023/01/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case report: Streptococcus pneumoniae pneumonia characterized by diffuse centrilobular nodules in both lungs. (2023/01/10) ♡
• Three doses of BNT162b2 COVID-19 mRNA vaccine establish long-lasting CD8(+) T cell immunity in CLL and MDS patients. (2023/01/10) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Safety and efficacy of dual PI3K-δ, γ inhibitor, duvelisib in patients with relapsed or refractory lymphoid neoplasms: A systematic review and meta-analysis of prospective clinical trials. (2023/01/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Notch2 pathway in mature B cell malignancies. (2023/01/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia. (2023/01/04) ♡
• Postoperative Complications in Chronic Lymphocytic Leukemia Patients Undergoing Mohs Surgery: Increased Risk of Bleeding-Related Complications From Ibrutinib. (2023/01/01) ♡
• Severe Postoperative Bleeding Secondary to Ibrutinib Intake. (2023/01/01) ♡
• Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients. (2023/01/01) ♡
• Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome. (2023/01/01) ♡
• Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study. (2023/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL? (2022/12/28) ♡
• Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia. (2022/12/28) ♡
• Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia. (2022/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Leukemia Cutis As the Initial Manifestation of Chronic Lymphocytic Leukemia Progression. (2022/12/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Syndrome of Remitting Seronegative Symmetrical Synovitis with Pitting Edema-A Rare but Treatable Condition in Palliative Medicine. (2022/12/26) ♡
• A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. (2022/12/25) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Multifocal Leukoencephalopathy in a Chemotherapy-Naive Patient With Chronic Lymphocytic Leukemia: A Case Report. (2022/12/25) ♡
• Biological Features of CD5+ CD19+ B1 Cell and Natural IgM (VH4-34) in Chronic Lymphocytic Leukemia vs. Multiple Sclerosis. (2022/12/24) ♡
• Updated Mortality Analysis of SELTINE, the French Cohort of Nuclear Workers, 1968-2014. (2022/12/23) ♡
• Correction: Chronic lymphocytic leukemia treatment algorithm 2022. (2022/12/22) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. SARS-CoV-2 vaccination in CLL: how often is enough? (2022/12/22) ♡
• Age- and Sex-Matched Normal Leukocyte Subset Ranges in the General Population Defined with the EuroFlow Lymphocyte Screening Tube (LST) for Monoclonal B-Cell Lymphocytosis (MBL) vs. Non-MBL Subjects. (2022/12/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. COVID-19 Vaccination Response and Its Practical Application in Patients With Chronic Lymphocytic Leukemia. (2022/12/20) ♡
• SARS-CoV-2 mRNA vaccination exposes progressive adaptive immune dysfunction in patients with chronic lymphocytic leukemia. (2022/12/20) ♡
• A survival prediction model and nomogram based on immune-related gene expression in chronic lymphocytic leukemia cells. (2022/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Chronic Myeloid Leukemia: Chronic Phase Presenting as Extramedullary Presentation. (2022/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Plasma cell myeloma following a prior diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. (2022/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Bleeding complication following a shave biopsy in a patient taking ibrutinib. (2022/12/15) ♡
• Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity. (2022/12/14) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.